ugn-104
Generic: mitomycin
ugn-104: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| UroGen Pharma Ltd. (URGN) | Phase 3 |
Clinical Trials (1)
A Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-104, a Novel Formulation of UGN-101, for the Treatment of Patients With Low-grade Upper Tract Urothelial Cancer (LG-UTUC)
Frequently asked questions
Who is developing ugn-104?
ugn-104 is being developed by UroGen Pharma Ltd..
How many clinical trials involve ugn-104?
BioSniper tracks 1 clinical trial involving ugn-104.
Get deeper analysis on ugn-104
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis